Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?
Longo
Dan L
DL
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D001943:Breast Neoplasms / Q000453:epidemiology / Q000209:etiology; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000453:epidemiology / Q000209:etiology; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D018570:Risk Assessment; D012307:Risk Factors
D018906:Antineoplastic Agents, Alkylating